Natixis Advisors Portfolio holdings
AUM
$63B
This Quarter Return
+8.03%
1 Year Return
+23.95%
3 Year Return
+105.73%
5 Year Return
+183.26%
10 Year Return
+413.93%
AUM
$21.4B
AUM Growth
+$21.4B
(+12%)
Cap. Flow
+$1.02B
Cap. Flow
% of AUM
4.75%
Top 10 Holdings %
Top 10 Hldgs %
16.69%
Holding
1,355
New
99
Increased
790
Reduced
412
Closed
50
Top Buys
| 1 |
Apple
AAPL
|
$69.4M |
| 2 |
Moderna
MRNA
|
$52.5M |
| 3 |
Sherwin-Williams
SHW
|
$51.5M |
| 4 |
Microsoft
MSFT
|
$41.3M |
| 5 |
Jack Henry & Associates
JKHY
|
$36.6M |
Top Sells
| 1 |
Canadian National Railway
CNI
|
$39.9M |
| 2 |
ON Semiconductor
ON
|
$36.6M |
| 3 |
HCA Healthcare
HCA
|
$29.3M |
| 4 |
Cummins
CMI
|
$26.5M |
| 5 |
Chevron
CVX
|
$23.4M |
Sector Composition
| 1 | Technology | 20.01% |
| 2 | Financials | 14.17% |
| 3 | Healthcare | 13.11% |
| 4 | Industrials | 11.16% |
| 5 | Consumer Discretionary | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alibaba
BABA
$322B
| $128M | 0.6% | 564,909 +15,690 | +3% | +$3.56M |
|
27
Adobe
ADBE
$151B
| $126M | 0.59% | 215,613 +18,736 | +10% | +$11M |
|
28
Cisco
CSCO
$274B
| $126M | 0.59% | 2,372,776 +120,217 | +5% | +$6.37M |
|
29
Novartis
NVS
$245B
| $125M | 0.58% | 1,370,883 -32,675 | -2% | -$2.98M |
|
30
Thermo Fisher Scientific
TMO
$186B
| $123M | 0.58% | 244,494 +36,479 | +18% | +$18.4M |
|
31
Morgan Stanley
MS
$240B
| $123M | 0.57% | 1,342,465 -189,349 | -12% | -$17.4M |
|
32
Texas Instruments
TXN
$184B
| $122M | 0.57% | 635,024 +32,781 | +5% | +$6.3M |
|
33
PayPal
PYPL
$67.1B
| $121M | 0.57% | 415,583 +24,212 | +6% | +$7.06M |
|
34
Union Pacific
UNP
$133B
| $118M | 0.55% | 536,889 +27,037 | +5% | +$5.95M |
|
35
Home Depot
HD
$405B
| $117M | 0.55% | 367,566 +24,645 | +7% | +$7.86M |
|
36
Aon
AON
$79.1B
| $108M | 0.5% | 452,015 +39,103 | +9% | +$9.34M |
|
37
Starbucks
SBUX
$100B
| $103M | 0.48% | 922,044 +11,650 | +1% | +$1.3M |
|
38
Citigroup
C
$178B
| $103M | 0.48% | 1,449,637 +18,707 | +1% | +$1.32M |
|
39
Qualcomm
QCOM
$173B
| $101M | 0.47% | 704,901 -1,512 | -0.2% | -$216K |
|
40
Vanguard Mid-Cap Value ETF
VOE
$18.8B
| $98.7M | 0.46% | 702,283 +74,319 | +12% | +$10.4M |
|
41
Abbott
ABT
$231B
| $95.9M | 0.45% | 827,523 +31,026 | +4% | +$3.6M |
|
42
Medtronic
MDT
$119B
| $95.8M | 0.45% | 771,690 -69,987 | -8% | -$8.69M |
|
43
Procter & Gamble
PG
$368B
| $89.2M | 0.42% | 661,304 +86,631 | +15% | +$11.7M |
|
44
Intuit
INTU
$186B
| $88.4M | 0.41% | 180,252 +6,099 | +4% | +$2.99M |
|
45
Monster Beverage
MNST
$60.9B
| $87.7M | 0.41% | 960,411 -12,508 | -1% | -$1.14M |
|
46
Illumina
ILMN
$15.8B
| $86.1M | 0.4% | 181,881 -851 | -0.5% | -$403K |
|
47
Vanguard Small-Cap Growth ETF
VBK
$20.1B
| $85.6M | 0.4% | 295,287 +25,280 | +9% | +$7.33M |
|
48
NXP Semiconductors
NXPI
$59.2B
| $84.2M | 0.39% | 409,399 -2,340 | -0.6% | -$481K |
|
49
Novo Nordisk
NVO
$251B
| $81.8M | 0.38% | 976,267 -18,256 | -2% | -$1.53M |
|
50
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.05B
| $81.4M | 0.38% | 772,711 +55,080 | +8% | +$5.8M |
|